Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants.
D000547:Amantadine / Q000494:pharmacology*; D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology*; D001479:Basal Ganglia / Q000502:physiology*; D001522:Behavior, Animal / Q000187:drug effects*; D001923:Brain Chemistry / Q000187:drug effects; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D003342:Corpus Striatum / Q000033:anatomy & histology / Q000378:metabolism / Q000502:physiology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D006892:Hydroxydopamines / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D051379:Mice; D009448:Neurochemistry; D009638:Norepinephrine / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism; D013997:Time Factors
D000697:Central Nervous System Stimulants; D006892:Hydroxydopamines; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D000547:Amantadine; D000661:Amphetamine; D001058:Apomorphine; D004298:Dopamine; D009638:Norepinephrine